Nixon’s Research Continues with NIH Supplement
New York – Dr. Ralph Nixon, Director of Center for Dementia Research, has received a Supplement to the grant titled “Cell and Molecular Pathobiology of Alzheimer’s Disease” from the National Institute on Aging. According to Nixon, the supplement will help address an urgent need for additional perspectives on effective therapies for Alzheimer’s Disease. The research at the Nixon Lab advances a novel biological framework for understanding how AD develops and that identifies new directions for the therapy of AD and possibly other aging-related diseases. By exploiting this framework, Nixon and his team of scientists propose to validate multiple innovative therapeutic approaches for AD.